Pharmagen, Inc. (PHRX)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jan 16, 2026

Pharmagen Company Description

Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States.

The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals.

It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology, cardiovascular, and hormonal syndromes.

The company also manufactures and distributes health supplements, including Clotamin, a specialized over-the-counter multivitamin dietary supplement for patients on Warfarin.

In addition, it sells traditional pharmaceuticals to its distribution customers, such as antibiotics, vaccines, and other oral and injectable pharmaceuticals; and specializes in the formulation of drugs.

The company was formerly known as Sunpeaks Ventures, Inc. and changed its name to Pharmagen, Inc. in January 2013.

Pharmagen, Inc. is based in Silver Spring, Maryland.

Pharmagen, Inc.
CountryUnited States
IndustryMedical Distribution
SectorHealthcare
Employees24

Contact Details

Address:
9337 Fraser Avenue
Silver Spring, Maryland 20910
United States
Phone204-898-8160

Stock Details

Ticker SymbolPHRX
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS71715W1062
SIC Code5122

Key Executives

NamePosition
Mackie A. BarchFounder and Vice Chairman